Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also …
What to know about DGX
Quest Diagnostics Incorporated is a large Healthcare company with a mixed financial profile. It scores well on risk and valuation, but size is worth keeping an eye on.
Should you consider DGX?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
Quest Diagnostics Incorporated is a large-cap Healthcare company with a mixed overall financial profile — it is in the lower half of its Healthcare peers (39 of 59).
-
Profitability is roughly average for the S&P 500 — not a standout in either direction.
-
Valuation is in the middle of the pack — neither obviously cheap nor stretched.
-
The company is growing at a reasonable pace — not the fastest, but consistently moving in the right direction.
-
There is a small dividend (0.02%), but income-focused investors will likely find better yields elsewhere in the market.
-
Risk is relatively low — the stock tends to be less volatile than the broader market, which typically means a smoother ride during uncertain periods.
-
This is a mixed picture — real strengths in some areas, but areas that need watching too. Do your homework on the sector before deciding.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how DGX compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 21.55 | Above avg |
| Forward P/E | 16.71 | Above avg |
| PEG Ratio | 1.55 | Above avg |
| Price to Sales | 1.91 | Above avg |
| Price to Book | 2.94 | Above avg |
| EV/EBITDA | 12.87 | Above avg |
| Earnings Yield | 4.64% | Above avg |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 33.28% | Average |
| Operating Margin | 14.20% | Average |
| Net Profit Margin | 9.08% | Average |
| Return on Equity | 14.54% | Average |
| Return on Invested Capital | 6.35% | Above avg |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 9.20% | Above avg |
| Revenue Growth (3Y CAGR) | 3.74% | Average |
| EPS Growth (YoY) | 15.50% | Average |
| Free Cash Flow Growth | 49.50% | Top 25% |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 1.18 | Average |
| Debt to Equity | 0.83 | Above avg |
| Interest Coverage | 5.76 | Average |
| Altman Z-Score | 3.32 | Above avg |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | 1.71% | Average |
| Payout Ratio | 36.02% | Average |
| Dividend Growth (5Y) | -7.26% | Above avg |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 6.14% | Above avg |
| OCF to Sales | 16.40% | Average |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.59 | Top 25% |
| Volatility (30-Day) | 20.52% | Top 25% |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 3.11% | Above avg |
| Avg. Analyst Rating | 2.11 | Average |
| Target Upside % | 14.58% | Above avg |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 21.59B | Below avg |
How does DGX compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to DGX — based on their financial profile.